PI-LAB-2025-183

Cagrilintide, Independent Lab Report

Cagrilintide 5mg · Meridian Health Direct

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 97.3% met the stated ≥98% claim. Content measured 98.0% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
97.3%

Label claimed ≥98%

Content accuracy
98%

4.9mg measured against 5mg claimed

Test recency
Current cycle

Published 12 months ago

Specimen PI-LAB-2025-183 Tested by Vantage Analytical Labs 8 samples tested from this company Purity & Testing score 97/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 97.3% Within analytical tolerance
Identity (MS) Cagrilintide Confirmed Matches label
Content 5 mg 4.9 mg Within 5% of label

Methodology & chain of custody

RP-HPLC purity with electrospray ionisation mass confirmation.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Vantage Analytical Labs. See our full testing methodology.

Lot / batch
B1655-25
Purchased
Analysed
Published
Laboratory
Vantage Analytical Labs
Test type
Full panel (purity, identity, content, endotoxin)

Original laboratory report: PI-LAB-2025-183-report.pdf (document delivery arrives with the production storage backend)

More Tests, Meridian Health Direct

Semaglutide (Oral)
Purity 97.5% Verified
Orforglipron
Purity 98.1% Verified
Cagrilintide
Purity 97.0% Verified

More Tests, Cagrilintide

Cagrilintide Lumen Research Supply
Purity 98.7% Verified
Cagrilintide Lumen Research Supply
Purity 98.5% Verified
Cagrilintide Meridian Health Direct
Purity 97.0% Verified